Drug Research
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying...
Drug Research
J&J Identifies Lead COVID-19 Vaccine Candidate, Commits to Supply 1 Billion Vaccines Worldwide
Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant said it selected a lead vaccine candidate and plans to...
Drug Research
Destroying DNA to Save the Genome – Study Offers New Insights into Sepsis and its Treatment
Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment. Now, researchers from Tata Memorial Centre, India,...
Drug Research
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of...
Articles
Leveraging synergies in pre-clinical biomedical R&D – pharmaceutical companies benefit from new innovation models
Introduction: As the complexity of pharmaceutical research and development increases constantly, its innovation productivity defined as the successful approval and launch of truly novel drugs...
Drug Research
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site in Jumet, Belgium
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral...
Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.